AFLD 2015 FFBP vs Respondent M44

24 Sep 2015

In September 2014 the Fédération française de ballon au poing (FFBP) has reported an anti-doping rule violation against the respondent M44 after he refused to provide a sample for drug testing. The respondent initially didn’t produce enough urine for a sample and refused to wait to produce a complementary sample.

After notification and an ordered provisional suspension the FFBP failed to settle the case within the time limit, the AFLD opened disciplinary proceedings against the respondent hereafter.
Considering the circumstances and without a statement in his defence the AFLD decides on 24 September 2015 to impose a 3 year period of ineligibility on the respondent starting on the date of the provisional suspension, i.e. on 6 December 2014.

AFLD 2015 FFJDA vs Respondent M42

10 Sep 2015

Related cases:

  • AFLD 2008 FFJDA vs Respondent M29
    April 17, 2008
  • AFLD 2016 FFJDA vs Respondent M49 - Appeal
    April 21, 2016

In December 2014 the the French Federation for Judo, Jujitsu, Kendo and Associated Disciplines (FFJDA), has reported a second anti-doping rule violation against the Respondent M42 for three whereabouts filing failures within a 12 month period.

After notification and a provisional suspension the FFJDA imposed on 5 February 2015 a 10 month period of ineligibility on the Respondent. Hereafter the AFLD appealed the FFJDA decision and started new disciplinary proceedings against respondent M42.

The Respondent admitted his whereabouts failures, expressed his regrets and he disputed the reliability and flexibility of ADAMS to report his new whereabouts within 17 hours. He argued that his failures were not intentional and that his samples tested negative.

The AFLD finds that the respondent failed to report his whereabouts three times and failed to prove that he made additional and appropriate efforts to report his new whereabouts on time to the AFLD.

Considering this is the Respondent's second anti-doping rule violation the AFLD decides on 10 september 2015 to annul the FFJA decision of 5 February 2015 and to impose a 2 year period of ineligibility on the Respondent, starting on de date of the provisional suspension, i.e. on 11 December 2014.

AFLD 2015 FFB vs Respondent M41

10 Sep 2015

In December 2014 the Fédération Française de Boxe (FFBoxe), the French Boxing Federation, has reported and anti-doping rule violation against the Respondent M41 after his sample tested positive for the prohibited substances ephedrine. clenbuterol and testosterone with at a T/E ratio above the WADA threshold.
After notification the respondent did not file a statement in his defence.

Decision:
To impose a 4 year period of ineligibility on the respondent starting on the date of the notification of the decision.

AFLD 2015 FFC vs Respondent M40

10 Sep 2015

Related case:
AFLD 2015 FFTri vs Respondent M73
December 16, 2015

In October 2015 the Fédération Française de Cyclisme (FFC), the French Cycling Federation, has reported and anti-doping rule violation against the Respondent M40 after his sample tested positive for the prohibited substances prednisone and prednisolone.
After notification a suspension was ordered by the FFC and the respondent failed to attend the hearing, nor did he file a statement in his defence.

Decision:
To impose a 2 year period of ineligibility on the respondent starting on the date of the notification of the decision.

Informed-Choice & Informed-Sport - Risks Behind Sports Supplements

4 Apr 2013

A brief overview of the risks surrounding sports supplements and how these can be solved. The video looks at how sports supplements get contaminated with WADA banned substances and how athletes can avoid inadvertent doping.

Check out
www.informed-sport.com
or
www.informed-choice.org
for more information on safer supplements.

Informed-Sport is a quality assurance programme for sports nutrition products, suppliers to the sports nutrition industry, and supplement manufacturing facilities. The programme certifies that all nutritional supplements and/or ingredients that bear the Informed-Sport logo have been tested for banned substances by the world class sports anti-doping lab, LGC. Athletes choosing to use supplements can use the search function above to find products that have been through this rigorous certification process.

Informed-Choice is a quality assurance program for sports nutrition products, suppliers to the sports nutrition industry, and supplement manufacturing facilities. The program certifies that all nutritional supplements and/or ingredients that bear the Informed-Choice logo have been tested for banned substances by the world class sports anti-doping lab, LGC.

Athletes choosing to use supplements can use the search function on http://www.informed-choice.org/ to find products that have been through this rigorous certification process.

show » details »
Type:
video

WADA - dietary supplements and their associated risks

10 Feb 2016

WADA Talks with Dietary Supplements Expert Ron Maughan, Professor of Sport and Nutrition at the Loughborough University.

Professor Ron Maughan discusses dietary supplements and their associated risks.

The views and opinions expressed in WADA Talks are those of the interviewees and do not reflect the views of the World Anti-Doping Agency (WADA)

show » details »
Type:
video

AAA 2015 No. 01 15 0005 6647 USADA vs Robert Lea

5 Jan 2016

Related case:
CAS 2016/A/4371 Robert Lea vs USADA )
May 4, 2016

In September 2015 the United States Anti-Doping Agency (USADA) has reported an anti-doping rule violation against the Athlete Robert Lea after his sample tested positive for the prohibited substance noroxycodone (metabolite of oxycodone).
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and was heard for the American Arbitration Association (AAA) Commercial Arbitration Tribunal.

USADA requested the Tribunal to impose a 4 year period of ineligibility on the Athlete for the intentional ingestion of a prohibited substance while in competition.

The Athlete admitted that he had used prescribed Percocet for his athletic injuries and without intention to enhance his performance. He stated that the medication was used out of competition more than 12 hours before the next competition and argued that a 3 month suspension from competition is appropriate.

Considering the circumstances the Panel concludes that the Athlete acted with significant fault because he failed to research the ingredients before using the medication out of competition and without intention to enhance his performance.

Therefore on 5 January 2016 the Tribunal decides to impose a 16 month period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 10 September 2015.

Anabolic-androgenic Steroid use and Psychopathology in Athletes : A Systematic Review

1 Jan 2015

Anabolic-androgenic Steroid use and Psychopathology in Athletes : A Systematic Review / Daria Piacentino, Georgios D. Kotzalidis, Antonio del Casale, Maria Rosaria Aromatario, Cristoforo Pomara, Paolo Girardi, Gabriele Sani. – (Current Neuropharmacology 13 (2015) 1 (January) : p. 101-121).

  • PMID: 26074746
  • PMCID: PMC4462035
  • DOI: 10.2174/1570159X13666141210222725

Content:

- Introduction
- Methods
• Eligibility Criteria
• Search Criteria and Critical Appraisal
- Results
• Search Results and Included Studies
• Study Characteristics
• Risk of Bias
• AASs and Mood Disorders
• AASs and Suicide
• AASs and Anxiety Disorders
• AASs, Somatoform and Eating Disorders
• AASs and Behavioral Disorders
• AASs and Psychosis
- Discussion
- Conclusions



Abstract

The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.

The Very High Premature Mortality Rate among Active Professional Wrestlers Is Primarily Due to Cardiovascular Disease

5 Nov 2014

The very high premature mortality rate among active professional wrestlers is primarily due to cardiovascular disease / C.W. Herman, A.S. Conlon, M. Rubenfire, A.R. Burghardt, S.J. McGregor. – (Public Library of Science one 9 (2014) 11 (5 November) : p. 1-7).
doi: 10.1371/journal.pone.0109945. eCollection 2014

Content:

- Introduction
- Methods
• Ethics Statement
• Calculations of Mortality Rates
• Survival Analysis
- Results
• Survival Estimates
- Discussion
- Conclusion
- References

PURPOSE:
Recently, much media attention has been given to the premature deaths in professional wrestlers. Since no formal studies exist that have statistically examined the probability of premature mortality in professional wrestlers, we determined survival estimates for active wresters over the past quarter century to establish the factors contributing to the premature mortality of these individuals.
METHODS:
Data including cause of death was obtained from public records and wrestling publications in wrestlers who were active between January 1, 1985 and December 31, 2011. 557 males were considered consistently active wrestlers during this time period. 2007 published mortality rates from the Center for Disease Control were used to compare the general population to the wrestlers by age, BMI, time period, and cause of death. Survival estimates and Cox hazard regression models were fit to determine incident premature deaths and factors associated with lower survival. Cumulative incidence function (CIF) estimates given years wrestled was obtained using a competing risks model for cause of death.
RESULTS:
The mortality for all wrestlers over the 26-year study period was.007 deaths/total person-years or 708 per 100,000 per year, and 16% of deaths occurred below age 50 years. Among wrestlers, the leading cause of deaths based on CIF was cardiovascular-related (38%). For cardiovascular-related deaths, drug overdose-related deaths and cancer deaths, wrestler mortality rates were respectively 15.1, 122.7 and 6.4 times greater than those of males in the general population. Survival estimates from hazard models indicated that BMI is significantly associated with the hazard of death from total time wrestling (p<0.0001).
CONCLUSION:
Professional wrestlers are more likely to die prematurely from cardiovascular disease compared to the general population and morbidly obese wrestlers are especially at risk. Results from this study may be useful for professional wrestlers, as well as wellness policy and medical care implementation.

Annual banned-substance review: the Prohibited List 2008 - analytical approaches in human sports drug testing - [2007-2008]

8 Jan 2009

Annual banned-substance review: the Prohibited List 2008 : analytical approaches in human sports drug testing / Mario Thevis, Tiia Kuuranne, Hans Geyer, Wilhelm Schänzer. - (Drug Testing and Analysis 1 (2009) 1 (January); p. 4-13)

  • PMID: 20355153
  • DOI: 10.1002/dta.9


Abstract

The list of prohibited substances and methods of doping issued by the World Anti-Doping Agency is updated and modified annually based on most recent developments and scientific data. Compounds and methods are maintained, added, or removed from the list, or they are placed in so-called monitoring programmes that have been established to obtain reliable data on the prevalence of particular substances and methods in- and/or out-of-competition. Consequently, doping control laboratories continuously update, modify and optimize existing screening and confirmation assays to ensure utmost comprehensiveness in detecting the prohibited and monitored substances as well as chemically and pharmacologically related analogs. The annual banned-substance review for human sports drug testing critically summarizes recent innovations in analytical approaches supporting the detection of established and newly outlawed substances and methods of doping. Literature from January 2007 through September 2008 as indexed in Medline and Web of Science was screened and articles on detection methods for substances and methods of doping in humans were compiled according to the 2008 Prohibited List of the World Anti-Doping Agency. Few new approaches were presented for individual doping agents and the majority of reports demonstrated new options for increasing the comprehensiveness of existing doping control assays. In addition, new techniques in separation and/or ionization of analytes complementary to commonly used procedures were described, which, so far, did not meet all requirements of sports drug testing.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin